
Abstract 1996: Nuclear factor (erythroid-derived 2)-like 2 promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinoma
Author(s) -
Hareton Leung,
Terence Lee
Publication year - 2018
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2018-1996
Subject(s) - sorafenib , hepatocellular carcinoma , cancer research , gene knockdown , metastasis , doxorubicin , medicine , biology , cell culture , cancer , chemotherapy , genetics